ERS International Congress 2015

ERS International Congress 2015

European Respiratory Society (ERS) International Congress 2015
Amsterdam, the Netherlands, 26 – 30 September

POSTERS

REG study: characterisation of real-life, longitudinal ICS adherence patterns in a UK asthma population
[Poster]

Investigating inhaler device mastery in pharmacist trainees
[Poster]

Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs)
[Poster]

Eligibility of patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
[Poster]

Dose-response effect of extra-fine particle vs fine particle inhaled corticosteroids on severe asthma exacerbations by sex
[Poster]

ABSTRACTS

Predicting asthma exacerbations in children – a real life observational study
Turner S, Burden A, Thomas M, Murray C, Price D
Eur Respir J 2015; 46(59): PA4511. [Full Text]

LATE-BREAKING ABSTRACT: One-year assessment of asthma control and quality of life in Europe: the LIAISON study (InternationaL cross-sectIonAl and longitudinal assessment on aSthma cONtrol)
Ingrassia E, Nicolini G, Guastalla D, Braido F, Brusselle G, et al.
Eur Respir J 2015; 46(59): PA4046. [Full Text]

Eligibility of patients with COPD for inclusion in trials of inhaled long-acting bronchodilator therapy
Halpin D, Price DB, Kerkhof M
Eur Respir J 2015; 46(59): PA3940. [Full Text]

Prevalence of serious post-training inhaler technique errors made by device-naïve patients using three different dry powder inhalers (DPIs)
Chrystyn H, Bosnic-Anticevich S, Roche N, Molimard M, Haughney J, et al.
Eur Respir J 2015; 46(59): PA3927. [Full Text]

Dose-response effect of small particle vs standard size particle inhaled corticosteroids on severe asthma exacerbations by sex
Price DB, Colice G, Grigg J, Martin RJ, Guilbert TW, et al.
Eur Respir J 2015; 46(59): PA1245. [Full Text]

REG study: real-life, longitudinal ICS adherence patterns in a UK asthma population
Dima A, Souverein P, Koster E, Chisholm A, Price D, et al.
Eur Respir J 2015; 46(59): PA1238. [Full Text]

Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Machnicki G, Lotya J, Ong SH, Alvares L, Sagkriotis A, et al.
Eur Respir J 2015; 46(59): PA1064. [Full Text]

QVA149 compared with salmeterol/fluticasone (SFC) on exacerbations and its correlation with baseline blood eosinophils: a pooled analysis of LANTERN and ILLUMINATE
Wedzicha JA, Price D, Mezzi K, Fogel R, Banerji D
Eur Respir J 2015; 46(59): PA1005. [Full Text]

Investigating inhaler device mastery in pharmacist trainees
Bosnic-Anticevich S, Lim D, Steel J, Kritikos V, Nikolaou V, et al.
Eur Respir J 2015; 46(59): PA701. [Full Text]

Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations
Thomas M, Price D, Blakey J, Josephs L, Pavord I, et al.
Eur Respir J 2015; 46(59): OA4793. [Full Text]

Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS)
Price D, Van Eickels D, Binek M, Khalid M, Herings RMC, et al.
Eur Respir J 2015; 46(59): OA3259. [Full Text]